Patents by Inventor Karin Rapp

Karin Rapp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION
    Publication number: 20250281413
    Abstract: The present invention relates to the field of pharmacy, particularly to a pharmaceutical composition for oral administration comprising a pharmaceutical composition for oral administration comprising: (a) an inert substrate, and (b) a mixture comprising N-(3-(6-amino-5-(2-(N-methylacrylamido)ethoxy)pyrimidin-4-yl)-5-fluoro-2-methylphenyl)-4-cyclopropyl-2-fluorobenzamide, or a pharmaceutically acceptable salt thereof, or a free form thereof, and at least one binder. The present invention also relates to a process for preparing said pharmaceutical composition for oral administration; and to the use of said pharmaceutical composition in the manufacture of a medicament.
    Type: Application
    Filed: January 24, 2022
    Publication date: September 11, 2025
    Inventors: Michael JUHNKE, Karin RAPP, Kim-Hien SIN
  • REMIBRUTINIB FOR USE IN THE TREATMENT OF HIDRADENITIS SUPPURATIVA
    Publication number: 20250099465
    Abstract: The present disclosure relates to methods for treating and/or preventing Hidradenitis Suppurativa in a subject having such disease or condition comprising administering a therapeutically effective dose of LOU064. Also disclosed are medicaments, dosing regimens, pharmaceutical compositions, combinations, dosage forms, and kits for use in the disclosed uses and methods.
    Type: Application
    Filed: February 27, 2023
    Publication date: March 27, 2025
    Inventors: Souvik BHATTACHARYA, Bruno BIETH, Bruno CENNI, Gordon GRAHAM, Michael JUHNKE, Christian LOESCHE, Karin RAPP, Kim-Hien SIN, Jonas Benjamin ZIERER
  • METHODS OF TREATMENT USING LOU064
    Publication number: 20250032488
    Abstract: The present disclosure relates to methods of treating and/or preventing IgE driven allergic reaction to one or more allergens, preferably food allergens, in subjects having such disease or condition, comprising administering a therapeuticallly effective dose of LOU064.
    Type: Application
    Filed: December 12, 2022
    Publication date: January 30, 2025
    Inventors: Souvik BHATTACHARYA, Bruno BIETH, Bruno CENNI, Gordon GRAHAM, Michael JUHNKE, Monica LIGUEROS-SAYLAN, Dan Dragos MIHAILESCU, Karin RAPP, Kim-Hien Sin, Bridget Danielle STUART
  • LOU064 FOR TREATING MULTIPLE SCLEROSIS
    Publication number: 20240350489
    Abstract: The invention concerns method of treating multiple sclerosis (MS) by administering a therapeutically effective dose of LOU064 or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 1, 2022
    Publication date: October 24, 2024
    Inventors: Souvik BHATTACHARYA, Bruno BIETH, Bruno CENNI, Peter END, Gordon GRAHAM, Michael JUHNKE, Rajesh Singh KARAN, Allison Donna MANN, Etienne PIGEOLET, Karin RAPP, Kim-Hien SIN, Huixin YU, Ying ZHANG
  • Pharmaceutical compositions
    Patent number: 10188696
    Abstract: The invention provides lipid-based pharmaceutical compositions comprising alisporivir.
    Type: Grant
    Filed: May 12, 2016
    Date of Patent: January 29, 2019
    Assignees: Novartis AG, Debiopharma S.A.
    Inventors: Elisabete Goncalves, Karin Rapp, Bertrand Sutter, Frank Stowasser, Bjoern Trupp, Sebastian Chabaut, Julien Thorens
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20160367624
    Abstract: The invention provides lipid-based pharmaceutical compositions comprising alisporivir.
    Type: Application
    Filed: May 12, 2016
    Publication date: December 22, 2016
    Applicants: Novartis AG, DEBIOPHARM S.A.
    Inventors: Elisabete Goncalves, Karin Rapp, Bertrand Sutter, Frank Stowasser, Bjoern Trupp, Sebastian Chabaut, Julien Thorens
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20140005123
    Abstract: The invention provides lipid-based pharmaceutical compositions comprising alisporivir.
    Type: Application
    Filed: December 12, 2011
    Publication date: January 2, 2014
    Applicants: DEBIOPHARM S.A., NOVARTIS AG
    Inventors: Elisabete Goncalves, Karin Rapp, Bertrand Sutter, Frank Stowasser, Bjoern Trupp, Sebastian Chabaut, Julien Thorens
  • PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS IN THE TREATMENT OF SKIN DISORDERS
    Publication number: 20110021530
    Abstract: Methods of treating an SCD-mediated skin disorder or condition in a mammal, preferably a human, including administering to a mammal in need thereof a compound of formula (I): where x, y, W, V, R2, R3, R4, R5, R6, R6a, R7, R7a, R8, R8a, R9 and R9a are defined herein, and compositions including a compound of formula (I).
    Type: Application
    Filed: February 19, 2009
    Publication date: January 27, 2011
    Applicants: XENON PHARMACEUTICALS INC., NOVARTIS AG
    Inventors: Andreas Billich, Michael D. Winther, Yigal Paul Goldberg, Gesine Winzenburg, Karin Rapp, Andreas Fritze